Leadership Team

Dr. Anand Manoharan is a medical microbiologist and public health scientist. He completed his MSc and PhD from Christian Medical College, Vellore India and subsequently trained as a post doctoral fellow at New York Medical College. Dr. Manoharan was selected as a Fogarty International Fellow (2007-2009)  and completed his MPH (Global Health) from Tufts University, Boston in 2009. In 2020 he completed his Executive Masters in Business Management (EMBA) program from Indian Institute of Technology- Madras.

Currently Dr. Manoharan is the Scientific and Antibiotic Susceptibility Program Lead at GSK, Brentford, UK and based out of Worli, Mumbai. He leads the multicountry Surveillance of Antimicrobial Resistance (SOAR) program at GSK. Previously, Dr. Manoharan was a scientist with the Department of Medicine Unit I and Infectious Diseases, CMC, Vellore.

Dr. Manoharan’s areas of research interest include surveillance of antimicrobial resistance (AMR) including characterizing mechanisms of resistance, invasive pneumococcal disease and understanding etiology of undifferentiated fevers Dr. Manoharan has led many multicentric surveillance studies including the Alliance for Surveillance of Invasive Pneumococci (ASIP) which to date is among the largest pediatric invasive pneumococcal disease surveillance effort in India, results of which were published in the Lancet Infectious Diseases in 2017.

Dr. Manoharan has evaluated several new antibiotics prior to market launch and published these findings, this include netilmicin, isepamicin, ertapenem, tigecycline and cefepime-tazobactam. He has undertaken laboratory studies to understand the in vitro activity of these antibiotics, mechanisms of resistance and set interpretative microbiological breakpoints.

Dr. Manoharan has been the recipient of research grants from Government agencies, International foundations and pharmaceutical industry. He has presented his research findings in various international and national conferences and to date has 84 publications, majority of which are in the area of AMR surveillance. He serves on the Editorial Board of Clinical Epidemiology and Global Health (Elsevier). He is closely associated with School of Biosciences and Technology, Vellore Institute of Technology (VIT) having been a Research Advisor/ Co -Guide to 4 PhD students working on AMR and Bioinformatics.